In March 2025, the company introduced new designs for a immediate-to-consumer providing of its Wegovy weight loss drug. The company recognized a whole new pharmacy, referred to as NovoCare, which would demand prospects $499 every month for access to the drug, fewer than fifty percent the price of the drug through other pharmaceutical distribution n